Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.198%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

14 Oct 2025 07:00

RNS Number : 1788D
Ashmore Group PLC
14 October 2025
 

Ashmore Group plc 14 October 2025

FIRST QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc (Ashmore, the Group), the specialist Emerging Markets asset manager, announces the following update to its assets under management (AuM) in respect of the quarter ended 30 September 2025.

Assets under management

Investment theme

Actual30 June 2025

(US$ billion)

Estimated30 September 2025

(US$ billion)

- External debt

7.4

7.2

- Local currency

14.2

14.4

- Corporate debt

5.2

5.4

- Blended debt

11.7

12.1

Fixed income

38.5

39.1

Equities

7.5

7.8

Alternatives

1.6

1.8

Total

47.6

48.7

 

AuM increased by US$1.1 billion (+2%) over the period, comprising positive investment performance of US$1.4 billion and net outflows of US$0.3 billion.

Net flows continued to improve through both higher subscriptions and a further reduction in redemptions, as investors increasingly recognise the outperformance and relative attractions of emerging markets. There were net inflows in the local currency, equity and alternatives themes, and a net outflow in external debt driven by institutional activity early in the period. Net flows in blended debt and corporate debt were flat. In aggregate, this activity delivered a net inflow to the Group's globally-managed strategies.

Emerging markets delivered strong returns over the three months, with fixed income indices rising by 3% to 5%, and the main equity indices returning around 10%. Ashmore's active management approach continues to generate outperformance for clients across the Group's fixed income and equity strategies.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging markets continue to perform strongly, which, along with Ashmore's alpha delivery for clients, is leading to broad client engagement and increasing momentum across the business. This has led to a further improvement in net flows this quarter. The Group has a consistent strategy for growth and the focus on building greater scale in equities and alternatives is successfully delivering net inflows in these investment themes.

"Given the positive emerging markets backdrop, evident risks to investors' overweight positions in the US, and Ashmore's continued investment outperformance, the Group is well-positioned to capture additional flows as investors increasingly look to shift allocations away from the US including into emerging markets."

Notes

Local currency AuM includes US$7.8 billion of AuM managed in overlay/liquidity strategies (30 June 2025: US$7.9 billion).

 

For further information please contact:

Ashmore Group plc Paul MeasdayInvestor Relations +44 (0)20 3077 6278 ir@ashmoregroup.com

Cardew Group Tom Allison +44 (0)7789 998020Will Baldwin-Charles +44 (0)7834 524833 ashmore@cardewgroup.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFRISLVLIE
Date   Source Headline
16th Sep 20204:09 pmRNS2020 Annual Financial Report and Notice of AGM
11th Sep 20207:00 amRNSFinal Results
14th Jul 20207:00 amRNSTrading Statement
23rd Jun 20205:40 pmRNSDirector/PDMR Shareholding
19th Jun 20206:07 pmRNSDirector/PDMR Shareholding
19th Jun 20206:04 pmRNSHolding(s) in Company
27th Apr 20203:33 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:44 pmRNS2019 AGM voting result update statement
1st Apr 20209:51 amRNSDirector/PDMR Shareholding
16th Mar 20203:29 pmRNSHolding(s) in Company
13th Mar 20206:21 pmRNSDirector/PDMR Shareholding
7th Feb 20204:50 pmRNSDirector/PDMR Shareholding
7th Feb 20204:49 pmRNSHolding(s) in Company
6th Feb 20207:00 amRNSHalf-year Report
15th Jan 20207:00 amRNSTrading Statement
10th Dec 20199:16 amRNSDirector/PDMR Shareholding
9th Dec 20192:08 pmRNSDirector/PDMR Shareholding
11th Nov 201912:17 pmRNSDirector/PDMR Shareholding
21st Oct 201911:42 amRNSDirector Declaration
18th Oct 20193:32 pmRNSResult of AGM
16th Oct 20191:08 pmRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSTrading Statement
30th Sep 20195:38 pmRNSDirector/PDMR Shareholding
30th Sep 20195:33 pmRNSDirector/PDMR Shareholding
18th Sep 201912:04 pmRNSDirector/PDMR Shareholding
18th Sep 201912:01 pmRNSDirector/PDMR Shareholding
16th Sep 20192:07 pmRNS2019 Annual Report and Notice of AGM
6th Sep 20197:00 amRNSFinal Results
12th Jul 20197:00 amRNSTrading Statement
18th Apr 20195:08 pmRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSTrading Statement
5th Apr 20198:57 amRNSDirector/PDMR Shareholding
3rd Apr 20194:37 pmRNSDirector/PDMR Shareholding
3rd Apr 20194:30 pmRNSHolding(s) in Company
14th Mar 20194:50 pmRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSHalf-year Report
15th Jan 20197:00 amRNSTrading Statement
10th Dec 20182:14 pmRNSDirector/PDMR Shareholding
19th Oct 20185:08 pmRNSResult of AGM
12th Oct 20187:00 amRNSTrading Statement
1st Oct 20188:13 amRNSTotal Voting Rights
18th Sep 20186:04 pmRNSDirector/PDMR Shareholding
18th Sep 20186:00 pmRNSDirector/PDMR Shareholding
13th Sep 20184:16 pmRNSHolding(s) in Company
13th Sep 20184:11 pmRNSNotice of AGM
11th Sep 20185:19 pmRNSHolding(s) in Company
11th Sep 20185:04 pmRNSTreasury Shares
7th Sep 20187:00 amRNSFinal Results
6th Sep 20181:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.